advertisement

11.13.3 Betablocker and brimonidine (49)

Showing records 1 to 25

Display only abstracts from IGR 15-4 in classification 11.13.3 Betablocker and brimonidine

92583 Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma
Park SW
Japanese Journal of Ophthalmology 2021; 65: 295-305 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Kim JM
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92583 Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma
Kim JM
Japanese Journal of Ophthalmology 2021; 65: 295-305 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Kim TW; Park SW
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92583 Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma
Lee JW; Maglambayan J
Japanese Journal of Ophthalmology 2021; 65: 295-305 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Park HL; Hwang YH
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92583 Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma
Simonyi S; Park KH
Japanese Journal of Ophthalmology 2021; 65: 295-305 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Jeoung JW; Kim CY
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Taka E; Karavasili C; Bouropoulos N; Moschakis T; Andreadis DDD; Zacharis CKK; Fatouros DGG
Pharmaceuticals (Basel, Switzerland) 2020; 13: (IGR: 21-3)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Samy KE; Cao Y; Kim J; Konichi da Silva NR; Phone A; Bloomer MM; Bhisitkul RB; Desai TA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

76975 A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzo
Gómez-Aguayo F; Paczka JA; Leñero-Córdova R; Jiménez-Román J; Davila-Villarreal J; Hartleben C; Baiza-Durán L; Olvera-Montaño O; García-Velez F; Muñoz-Villegas P
Ophthalmology and therapy 2018; 7: 145-156 (IGR: 19-3)

74650 A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure
Hartleben C; Parra JC; Batoosingh A; Bernstein P; Goodkin M
Journal of Ophthalmology 2017; 2017: 4586763 (IGR: 19-1)

65918 Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5 % timolol in normal-tension glaucoma patients
Kim JM; Kim TW; Kim CY; Kim HK; Park KH
Japanese Journal of Ophthalmology 2016; 60: 20-26 (IGR: 17-3)

61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Kumbar SK; Mirje M; Moharir G; Bharatha A
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8 (IGR: 17-1)

60147 Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
García-López A
BMC Ophthalmology 2014; 14: 161 (IGR: 16-4)

60175 The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
Radcliffe NM
Clinical Ophthalmology 2014; 8: 2541-2549 (IGR: 16-4)

60147 Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
Paczka JA; Jiménez-Román J; Hartleben C
BMC Ophthalmology 2014; 14: 161 (IGR: 16-4)

59424 Intraocular pressure-lowering effects of commonly used fixed combination drugs with timolol in the management of primary open angle glaucoma
Ozer MA; Acar M; Yildirim C
International Journal of Ophthalmology 2014; 7: 832-836 (IGR: 16-3)

58974 Efficacy and tolerability of fixed-combination brinzolamide/timolol in latin american patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination
Alezzandrini A; Hubatsch D; Alfaro R
Advances in Therapy 2014; 31: 975-985 (IGR: 16-3)

55211 Chick chorioallantoic membrane model for in ovo evaluation of timolol maleate-brimonidine tartrate ocular inserts
Ravindran VK; Repala S; Subadhra S; Appapurapu AK
Drug Delivery 2014; 21: 307-314 (IGR: 15-4)

54679 Evaluation of brimonidine-timolol fixed combination in patients of primary open-angle glaucoma
Joshi SR; Akat PB; Ramanand JB; Ramanand SJ; Karande VB; Jain SS
Indian Journal of Ophthalmology 2013; 61: 765-767 (IGR: 15-3)

53984 Comparison of Dorzolamide/Timolol Versus Brimonidine/Timolol Fixed Combination Therapy in the Management of Steroid-induced Ocular Hypertension
Seymenoğlu G; Baser EF; Oztürk B; Gülhan C
Journal of Glaucoma 2015; 24: 111-116 (IGR: 15-2)

53502 Comparison of 24-hour Intraocular Pressure Reduction Obtained with Brinzolamide/Timolol or Brimonidine/Timolol Fixed-Combination Adjunctive to Travoprost Therapy
Konstas AG; Holló G; Haidich AB; Mikropoulos DG; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Konidaris V; Samples JR
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 652-657 (IGR: 15-2)

54036 Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily
Moisseiev E; Kurtz S; Lazar M; Shemesh G
Clinical Ophthalmology 2013; 7: 1269-1273 (IGR: 15-2)

52379 Effects of Dorzolamide-Timolol and Brimonidine-Timolol on Retinal Vascular Autoregulation and Ocular Perfusion Pressure in Primary Open Angle Glaucoma
Feke GT; Rhee DJ; Turalba AV; Pasquale LR
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 639-645 (IGR: 15-1)

• «
• 1
• 2
• »